B+
Bull case
30%
Probability
Target price
$60.00
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
AHR
American Healthcare REITDNYSE / Equity Real Estate Investment Trusts (REITs)
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
45%
Probability
Target price
$55.00
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$44.00
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-05-09
Recent news sentiment (30D)
-31.2
Negative
Company
-
Unavailable
Macro
-31.2
Negative
Pulse
-
Unavailable
Weekly research (10D)
-46.0
Negative
Sentiment proxy
+64.7
Score
AI commentary
Immediate price reaction was constructive: the checked finance tape showed AHR at $51.71 on 2026-05-08 versus the 2026-05-07 anchor close of $49.60, roughly a 4.2% move higher after the release. News tone is positive because the company raised guidance, but delayed analyst revision evidence was not clearly available in checked sources by 2026-05-09, so this still reads more like a favorable earnings follow-up than a high-conviction thesis change. Social context was not provided in the packet.
RankAlpha Sentiment Codex - 2026-05-09
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-07eventQ1 print beat on NFFO and management raised 2026 operating guidanceMedium impact
AHR reported Q1 2026 NFFO of $0.50 per diluted share, 12.1% total portfolio same-store NOI growth, and raised full-year NFFO guidance to $2.03-$2.09 from $1.99-$2.05 while lifting same-store NOI guidance to 9.0%-12.0% from 7.0%-11.0% [#8-K-2026-05-07]. A checked secondary earnings summary also indicated FFO beat consensus by $0.03 while revenue missed consensus.
2026-06-30catalystATM forward-sale overhang remains material despite better leverageMedium impact
As of May 7, 2026, AHR had 10,498,207 unsettled forward-sale shares tied to about $527.4 million of gross proceeds, which helps fund acquisitions but leaves a notable equity overhang even after net debt to annualized adjusted EBITDA improved to 3.0x from 3.4x [#8-K-2026-05-07].
2026-12-31catalystAcquisition pipeline and added credit capacity support continued external growthHigh impact
Management disclosed over $650 million of investments pipeline not yet closed, completed about $162.8 million of new SHOP investments in Q1, and after quarter-end expanded the unsecured revolver to $800 million within a $1.35 billion total credit facility [#8-K-2026-05-07]. If closings convert without margin slippage, growth could continue into late 2026.
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-09 • Updated nightlySource: Internal modelMethodology